PMTS

PMTS is a leader in U.S. payment-card production, personalization and instant-issuance SaaS, and the top line is healthy: FY2025 revenue of $544M grew +13.1% and the multi-year trend is up (FY21 $375M → FY25 $544M). Cash generation is the real bright spot — operating cash flow jumped +37.4% to $59.5M, comfortably funding $18.2M of capex (itself up +96% as management invests in capacity), for roughly $41M of free cash flow against a $234M market cap. On EV/EBITDA the stock looks inexpensive: operating income of $54.8M plus $22.5M D&A is ~$77M EBITDA versus an enterprise value of ~$500M (market cap + $287M long-term debt − $21.7M cash), or about 6.5x. P/S of 0.4 is undemanding.

The problem is that growth isn't reaching the bottom line. Net income has fallen every year since the FY2022 peak — $36.5M → $24.0M → $19.5M → $14.9M (−23.4% in FY2025) — and diluted EPS dropped −23.8% to $1.25. Gross profit was flat (−0.7%) while revenue rose 13%, so gross margin compressed to 31.3% and net margin sits at just 2.8%. The MD&A and Risk Factors point to why: management flags tariffs and trade policy as having 'had and may continue to have a material adverse effect,' single-source supply-chain and inflationary cost pressure they may be unable to pass through, and the drag/integration risk from the Arroweye acquisition. This is a business where volume is growing but pricing and cost dynamics are squeezing profitability.